District Court Interprets EKRA
FDA Law
JANUARY 6, 2022
S&G Labs alleged during the litigation that they are paid on a “per test” basis by third party insurers, government agencies under the Medicare and Medicaid programs, and direct “self-pay” by some individuals. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. EKRA Issue.
Let's personalize your content